← Eichor
Study identifier: NCT07234903 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

ARC-IM Therapy To Support and Promote Recovery of Ambulatory Functions in People With Subacute and Chronic Spinal Cord Injury

Condition: Spinal Cord Injury · SCI · SCI - Spinal Cord Injury  ·  Sponsor: Ecole Polytechnique Fédérale de Lausanne

PhaseNA
Planned participants12
Who can joinAll sexes, 18 Years to 65 Years
Healthy volunteersNo

About this study

The EIGER study aims to evaluate the safety and preliminary efficacy of ARC-IM Therapy (Epidural Electrical Stimulation) to support and promote recovery of ambulatory functions, such as walking, in people with subacute and chronic spinal cord injury.

This description comes directly from the study's public registry record.

Talk to the study team

Jocelyne Bloch, Prof. Dr. MD  ·  +41 79 556 29 51  ·  jocelyne.bloch@chuv.ch

Always discuss trial participation with your own doctor first.

Locations (2)

Schweizer Paraplegiker-Zentrum (SPZ)Nottwil, Canton of Lucerne, SwitzerlandNot Yet Recruiting
Centre Hospitalier Universitaire Vaudois (CHUV)Lausanne, Canton of Vaud, SwitzerlandRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07234903